Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| XBiotech Inc.XBIT · Entity 7044 | VP Finance & HR | November 19, 2021 | November 23, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
XBiotech Inc.
Report date November 19, 2021 · Filed November 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.67 · Expires 2031-11-19 | Direct | 35,000 |
Reported balance
After 2021-11-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-11-19 · Grant · Acquired 35,000 · Balance 35,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2021 Filed Nov 23, 2021 16:10 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantStock Option · Derivative | 35,000 | $0.00 Strike: $12.67 | $0.00 |
DisclosureSEC source: 0001209191-21-066401 · doc4.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2031-11-19 Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 11:33 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 27,692 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0001209191-20-049028 · doc4.xml · derivative · entry 4 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,692 shares Expires 2028-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 11:33 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $4.24 | $0.00 |
DisclosureSEC source: 0001209191-20-049028 · doc4.xml · derivative · entry 3 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2027-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 11:33 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Stock | 27,692 | $4.16 | $115,198.72 |
DisclosureSEC source: 0001209191-20-049028 · doc4.xml · nonDerivative · entry 2 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 11:33 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Stock | 30,000 | $4.24 | $127,200.00 |
DisclosureSEC source: 0001209191-20-049028 · doc4.xml · nonDerivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Options · Derivative | 12,500 | $0.00 Strike: $5.26 | $0.00 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · derivative · entry 15 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 12,500 shares Expires 2029-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Options · Derivative | 3,333 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · derivative · entry 14 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 3,333 shares Expires 2028-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Options · Derivative | 12,308 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · derivative · entry 13 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 12,308 shares Expires 2028-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Options · Derivative | 5,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · derivative · entry 12 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 5,000 shares Expires 2022-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock options · Derivative | 18,700 | $0.00 Strike: $7.50 | $0.00 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · derivative · entry 11 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 18,700 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Shares | 12,500 | $19.65 | $245,678.75 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 10 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Shares | 12,500 | $5.26 | $65,750.00 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 9 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Shares | 3,333 | $19.65 | $65,507.78 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 8 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Shares | 3,333 | $4.14 | $13,798.62 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 7 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Shares | 12,308 | $19.65 | $241,905.12 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 6 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Shares | 12,308 | $4.16 | $51,201.28 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 5 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Shares | 5,000 | $19.65 | $98,271.50 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 4 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Shares | 5,000 | $15.00 | $75,000.00 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 3 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Shares | 18,700 | $19.65 | $367,535.41 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 2 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:35 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Shares | 18,700 | $7.50 | $140,250.00 |
DisclosureSEC source: 0001209191-20-048337 · doc4.xml · nonDerivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 21, 2020 14:56 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock options · Derivative | 1,300 | $0.00 Strike: $7.50 | $0.00 |
DisclosureSEC source: 0001209191-20-047889 · doc4.xml · derivative · entry 3 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 1,300 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 21, 2020 14:56 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 1,300 | $19.30 | $25,090.00 |
DisclosureSEC source: 0001209191-20-047889 · doc4.xml · nonDerivative · entry 2 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 17, 2020 Filed Aug 21, 2020 14:56 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Shares | 1,300 | $7.50 | $9,750.00 |
DisclosureSEC source: 0001209191-20-047889 · doc4.xml · nonDerivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 15:06 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantStock Option · Derivative | 75,000 | $0.00 Strike: $10.36 | $0.00 |
DisclosureSEC source: 0001209191-19-055794 · doc4.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-11-06 Read SEC document |
| January 04, 2019 Filed Mar 4, 2019 16:48 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $5.26 | $0.00 |
DisclosureSEC source: 0001209191-19-015691 · doc4.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-01-04 Read SEC document |
| May 08, 2018 Filed May 11, 2018 11:39 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 40,000 | $4.16 Strike: $4.16 | $166,400.00 |
DisclosureSEC source: 0001209191-18-029438 · doc4.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On September 14, 2016 (the Grant Date) Fabrizio Bonanni was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market, with an expiry of ten years from the Grant Date. Half of the Options vest on December 20, 2016 and another half of the Options vest on June 20, 2017. Read SEC document |
| May 08, 2018 Filed Jun 21, 2018 16:48 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | GrantStock Option · Derivative | 40,000 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0001209191-18-038967 · doc4a.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-08 Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock options · Derivative | 8,201 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · derivative · entry 9 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,201 shares Expires 2018-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 8,201 | $4.75 | $38,954.75 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · nonDerivative · entry 6 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Stock | 8,201 | $2.50 | $20,502.50 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · nonDerivative · entry 5 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock options · Derivative | 62,200 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · derivative · entry 8 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,200 shares Expires 2018-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 62,200 | $4.76 | $296,159.08 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · nonDerivative · entry 4 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.77, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Stock | 62,200 | $2.50 | $155,500.00 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · nonDerivative · entry 3 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock options · Derivative | 9,599 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · derivative · entry 7 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 9,599 shares Expires 2018-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 9,599 | $4.48 | $42,987.20 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · nonDerivative · entry 2 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.85, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 21, 2018 Filed Mar 26, 2018 15:39 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Stock | 9,599 | $2.50 | $23,997.50 |
DisclosureSEC source: 0001209191-18-021609 · doc4.xml · nonDerivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2017 Filed Jun 23, 2017 14:51 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 30,000 | $4.24 Strike: $4.24 | $127,200.00 |
DisclosureSEC source: 0001209191-17-041616 · doc4a.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 30,000 shares Expires 2027-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2017 Filed Jun 23, 2017 14:12 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 30,000 | $4.24 Strike: $4.24 | $127,200.00 |
DisclosureSEC source: 0001209191-17-041606 · doc4.xml · derivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 30,000 shares Expires 2027-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On September 14, 2016 (the Grant Date) Fabrizio Bonanni was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market, with an expiry of ten years from the Grant Date. Half of the Options vest on December 20, 2016 and another half of the Options vest on June 20, 2017. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:01 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 19,573 | $15.00 | $293,595.00 |
DisclosureSEC source: 0001209191-16-150817 · doc4.xml · nonDerivative · entry 2 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:01 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Shares | 19,573 | $0.74 | $14,484.02 |
DisclosureSEC source: 0001209191-16-150817 · doc4.xml · nonDerivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 15:45 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock options · Derivative | 427 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001209191-16-140913 · doc4.xml · derivative · entry 3 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,573 Underlying: Common Stocks · 427 shares Expires 2016-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 15:45 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 427 | $15.00 | $6,405.00 |
DisclosureSEC source: 0001209191-16-140913 · doc4.xml · nonDerivative · entry 2 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 15:45 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Shares | 427 | $0.77 | $328.79 |
DisclosureSEC source: 0001209191-16-140913 · doc4.xml · nonDerivative · entry 1 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2016 Filed Nov 17, 2016 16:01 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock options · Derivative | 19,573 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-16-150817 · doc4.xml · derivative · entry 3 HAN QUEENA · CIK 0001638986 · VP Finance & HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stocks · 19,573 shares Expires 2016-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.